rhein has been researched along with Ovarian Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hou, HX; Kang, JK; Li, DR; Li, JY; Li, XX; Pang, HF; Tian, W; Wang, CM; Zhao, YH | 1 |
Han, NN; Li, X; Tao, L; Zhou, Q | 1 |
Guo, W; Li, W; Ren, B; Tang, Y; Xiao, N; Zhang, J; Zhang, L | 1 |
Chen, Y; Li, D; Peng, F; Tang, M; Zhong, Y; Zhou, G | 1 |
4 other study(ies) available for rhein and Ovarian Neoplasms
Article | Year |
---|---|
Confirming whether novel rhein derivative 4a induces paraptosis-like cell death by endoplasmic reticulum stress in ovarian cancer cells.
Topics: Anthraquinones; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Female; Humans; Mitochondria; Ovarian Neoplasms; Signal Transduction; Unfolded Protein Response | 2020 |
Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer.
Topics: Animals; Anthraquinones; Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Ovarian Neoplasms | 2018 |
Rhein Inhibits the Migration of Ovarian Cancer Cells through Down-Regulation of Matrix Metalloproteinases.
Topics: Anthraquinones; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; Matrix Metalloproteinases; Ovarian Neoplasms | 2019 |
Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Topics: Aminoquinolines; Anthraquinones; Cell Line, Tumor; Cell Movement; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Secreted; Neoplasm Invasiveness; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphorylation; Pyrimidines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-1 | 2017 |